Danish cross-sectional survey 12 713 Inflam arthritis (RA, PsA, SpA) pts & found lonliness in one-third (RA 32%; 36% in PsA & SpA) and highest in SpA w/ depression (66%). Loneliness was correlated w/ disease activity. https://t.co/Q3IswbIwe6 https://t.co/GNohOkkmEw

Full read overview of ILD & its Clinical Course inRheumatoid Arthritis. Metanalysis of 22 reports shows 6-19% of RA have ILD on HRCT. Article discusses early onset, progression and the monitoring and management of RA-ILD https://t.co/mqexPcruni https://t.co/One7XYn4wX

Analysis of 5 Nordic registries & 29,478 RA & 10,919 PsA pts initiating 1st bDMARD,s (& 362,087 pop controls). Incident ILD was higher in RA (HR 9.7) & PsA (4.4). but MTX co-use (vs non-use) did not incr ILD in RA (HR 0.9; 0.7, 1.2) or PsA (HR 1.0) https://t.co/xY8COh85Bw https://t.co/weJGirfhDX

🌟 ACUTE OPTIC NEURITIS - Differentials https://t.co/eE1Kbnmqc1

🌟 ASAS researchers recommend using axSpA as the overarching term for axial spondyloarthritis. They prefer radiographic-axSpA over ankylosing spondylitis. These changes aim to standardize terminology and improve clarity in diagnosis and treatment. https://t.co/0IhvwPOfm2 #ASAS https://t.co/H8ummkNmEj

Congratulations to Dr. Sebastian Sattui on his new @NIHAging R03: "Prevalence and Impact of frailty in older adults with polymyalgia rheumatica"! 🎉🎊🎉 https://t.co/JRzr4cZZhg

Treatment of Rheumatoid Arthritis (RA) associated Interstitial lung disease #ILD 2023 ACR/Chest Guideline #Rheumatology #MedTwitter https://t.co/hoW88BL2E2

Antidepressants for Pain are Weakly Effective University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence. https://t.co/ln5UguleUv https://t.co/CwZeHi3xWK

TREAT EARLIER - Methotrexate in Clinically Suspect Arthralgia Patients Lancet Rheumatology has published the results of the TREAT EARLIER trial, showing the prevention of rheumatoid arthritis may be enhanced by risk stratification, particularly in anti-citrullinated protein… https://t.co/1NYgYtYKIr https://t.co/fMMy2DzSxN

FDA decision explained on why they modified its rule on #Biosimilar interchangeability. Approved 15 yrs ago, now there are 50 Biosimilars in USA. Switching (interchangeability) studies are no longer needed based on the FDA experience over last 8 years. https://t.co/vpmgdVeDwz https://t.co/UAWnFQxugl

Neoself-antigens are targeted by autoreactive T cells clonally expanded in SLE. Neoself-antigen presentation results in clonally expanded neoself-reactive T cells, leading to the development of lupus-like disease in mice. https://t.co/iFXNLNRxO5 https://t.co/9TEJUqfEbo

Fasenra (benralizumab, an anti-IL-5 mAb) has been FDA approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA); approval based on MANDARA trial - H2H noninferior to mepolizumab at remission https://t.co/5tAPolUItK https://t.co/VHCNjACThw